| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9000769 | Farmacia Hospitalaria | 2005 | 8 Pages |
Abstract
Mitomycin C is an effective drug, but its use is associated with a high number of adverse events, some of which may lead to therapy discontinuation. Interferon α 2b has efficacy outcomes comparable to mitomycin C and a lower incidence of adverse effects, which are mostly mild in nature. The use of 5-fluorouracil is relegated to a second-tier status.
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmaceutical Science
Authors
A. Murcia López, J. Borrás Blasco, M.C. Alvarado Valero, A. Navarro Ruiz, M. González Delgado, J.J. MartÃnez Toldos,